Lion Point Capital »

Spruce Biosciences shares owned by Lion Point Capital

Quarter-by-quarter ownership of Spruce Biosciences shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.0k 1.0k 8.95

More positions owned by Lion Point Capital

Mineralys Therapeutics (MLYS)
Milestone Pharmaceuticals (MIST)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Ardelyx (ARDX)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Royalty Pharma Shs Class A (RPRX)
Disc Medicine (IRON)
Bridgebio Pharma (BBIO)
Geron Corporation (GERN)
Arcutis Biotherapeutics (ARQT)

View all positions for Lion Point Capital

Top funds holding Spruce Biosciences

Carlyle
Cable Car Capital
Ikarian Capital
Lion Point Capital
Advisor Group Holdings
UBS Group
Caldwell Sutter Capital

View all funds holding Spruce Biosciences